| mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.9 |
| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |